iProgen Biotech Inc. is an active federal corporation (corporation number 6899153). Its business number is 826908816. It was incorporated on Jan 3, 2008 under the Canada Business Corporations Act and its registered office is in Vancouver, British Columbia. Its annual returns are up to date, most recently for 2026. It has one director on record.
Corporate details
- Corporation number
- 6899153
- Business number
- 826908816
- Status
- Active
- Governing law
- Canada Business Corporations Act
- Incorporated
- Jan 3, 2008
- Corporation type
- Non-distributing corporation with 50 or fewer shareholdersAs declared in its 2026 annual return.
- Registered office
- Att: Michael J. MacLeod
4785 Chancellor Boulevard
Vancouver BC V6T 1C8 - Number of directors
- At least 1, at most 5As the articles allow.
Annual filings
- Anniversary date
- Jan 3The date of incorporation, amalgamation or continuance.
- Annual filing period
- Jan 3 to Mar 4 each year
- Last annual meeting
- Jun 27, 2025
| Year | Annual return | Annual meeting |
|---|---|---|
| 2026 | Filed | Jun 27, 2025 |
| 2025 | Filed | Jun 27, 2024 |
| 2024 | Filed | Jun 28, 2023 |
The last annual return filed, and each year since.
Directors
Loading the directors from the federal record...
Federal grants and contributions
18 agreements since 2018, worth $2,715,503 in all.
| Department | Program | Value | Starts |
|---|---|---|---|
| Global Affairs Canada | CIIP PDA – iProgen Biotech Inc. – 2025-26 | $3,167 | Sep 19, 2025 |
| Global Affairs Canada | CIIP PDA – iProgen Biotech Inc. – 2025-26 | $2,225 | Sep 16, 2025 |
| National Research Council Canada | Participation in the Canadian Life Sciences co-innovation mission to Japan - October 2025 | $4,063 | Aug 13, 2025 |
| National Research Council Canada | iProgen Biotech Inc.-2025-2026-1029463 | $5,083 | Jun 15, 2025 |
| National Research Council Canada | iProgen Biotech Inc.-2024-2025-1019163 | $9,851 | May 6, 2024 |
| National Research Council Canada | UKRI Biomanufacturing - 10098388 ADC Biocomputer - Development of Automated and Computerized Antibody Drug Conjugate Biomanufacturing Device | $853,470 | Mar 1, 2024 |
| Innovation, Science and Economic Development Canada | FR-04721 | $15,000 | Jun 9, 2023 |
| National Research Council Canada | iProgen Biotech Inc.-2023-2024-1007399 | $12,500 | Apr 1, 2023 |
| National Research Council Canada | iProgen Biotech Inc.-2023-2024-1006163 | $6,288 | Apr 1, 2023 |
| National Research Council Canada | CIIP Korea - Antibody Oligo Drug - Evaluation and Development of antibody conjugated oligos for targeted therapeutics development | $600,000 | Dec 1, 2021 |
As each federal department publishes them (proactive disclosure). A value is the agreement's total as last amended; the money may be paid over several years. The 10 most recent are shown. Search every federal grant.
Names
| Name | Form | In use since |
|---|---|---|
| iProgen Biotech Inc. | Name | Jan 3, 2008 |
Filings and certificates
| What | Date |
|---|---|
| Articles amended | Jun 2, 2014 |
| Incorporated | Jan 3, 2008 |
Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.